Daniele Dias

Prof. Daniele Dias

Universidade Tecnológica Federal do Paraná (UTFPR), Câmpus Ponta Grossa
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2002 in Brazilian Journal of Physics
Verified
Journal Article
Open access
PDF file
ABA. C. Bento
A. C. Bento
Daniele DiasDaniele Dias
Daniele Dias
LOL. Olenka
L. Olenka
AMAntonio Medina
Antonio Medina
MAURO LUCIANO BAESSOMAURO LUCIANO BAESSO
MAURO LUCIANO BAESSO

1 March 2006 in Journal of Luminescence
Verified
Journal Article
Closed access
RBR. Bonzanini
R. Bonzanini
Daniele DiasDaniele Dias
Daniele Dias
EGEmerson Girotto
Emerson Girotto
Edvani MunizEdvani Muniz
Edvani Muniz
MBM.L. Baesso
M.L. Baesso
ARA.F. Rubira
A.F. Rubira

29 May 2007 in Photochemistry and Photobiology
Verified
Journal Article
Closed access
PDF file
Daniele DiasDaniele Dias
Daniele Dias
ASAlysson Steimacher
Alysson Steimacher
ABAntonio Carlos Bento
Antonio Carlos Bento
AMAntonio Medina
Antonio Medina
MAURO LUCIANO BAESSOMAURO LUCIANO BAESSO
MAURO LUCIANO BAESSO

8 April 2019 in Catalysts
Verified
Journal Article
Open access
PDF file
Michel Zampieri FidelisMichel Zampieri Fidelis
Michel Zampieri Fidelis
EAEduardo Abreu
Eduardo Abreu
OSOnélia A. A. Dos Santos
Onélia A. A. Dos Santos
ECEduardo Chaves
Eduardo Chaves
RBRodrigo Brackmann
Rodrigo Brackmann
GGGiane Gonçalves
Giane Gonçalves
This study describes the experimental design and optimization of the photocatalytic reaction using the immobilized catalyst Fe/Nb2O5 in the degradation of Triclosan and 2.8-DCDD. The techniques employed to characterize the photocatalysts were: specific surface area, average pore volume, average pore diameter, photo-acoustic spectroscopy (PAS), X-ray diffraction (XRD), and scanning electron microscopy (SEM/EDS). The reaction parameters studied were pH, catalyst concentration, catalyst calcination temperature, and nominal metallic charge. The results indicated that the immobilized Fe/Nb2O5 catalysts were efficient in the degradation of Triclosan and 2.8-dichlorodibenzene-p-dioxin. The catalysts with nominal metal loading of 1.5% Fe calcined at 873 K showed the highest constant reaction rate and the lowest half-life 0.069 min−1 and 10.04 min. Tests in different matrices indicated that the photocatalytic reaction using aqueous solution containing Cl− is faster when compared with the ultrapure water matrix.

26 November 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GCGuilherme dos Anjos Camargo
Guilherme dos Anjos Camargo
Leandro FerreiraLeandro Ferreira
Leandro Ferreira
DSDiego José Schebelski
Diego José Schebelski
ALAmanda Martinez Lyra
Amanda Martinez Lyra
FBFernanda Malaquias Barboza
Fernanda Malaquias Barboza
PFPaulo Vitor Farago
Paulo Vitor Farago
Background: Tacrolimus (TAC) is a drug of natural origin used in conventional topical dosage forms to control atopic dermatitis. However, direct application of the drug often causes adverse side effects in some patients. Hence, drug nanoencapsulation could be used as an improved novel therapy to mitigate the adverse effects and enhance bioavailability of the drug. Methods: Physicochemical properties, in vitro drug release experiments, and in vivo anti-inflammatory activity studies were performed. Results: TAC-loaded nanocapsules were successfully prepared by the interfacial deposition of preformed polymer using poly(ε-caprolactone) (PCL). The nanoparticulate systems presented a spherical shape with a smooth and regular surface, adequate diameter (226 to 250 nm), polydispersity index below 0.3, and suitable electrical stability (−38 to −42 mV). X-ray diffraction confirmed that the encapsulation method provided mainly the drug molecular dispersion in the nanocapsule oily core. Fourier-transform infrared spectra suggested that nanoencapsulation did not result in chemical bonds between drug and polymer. In vitro drug dissolution experiments showed a controlled release with a slight initial burst. The release kinetics showed zero-order kinetics. As per the Korsmeyer–Peppas model, anomalous transport features were observed. TAC-loaded PCL nanocapsules exhibited excellent anti-inflammatory activity when compared to the free drug. Conclusions: TAC-loaded PCL nanocapsules can be suitably used as a novel nano-based dosage form to control atopic dermatitis.

21 March 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Jessica NadalJessica Nadal
Jessica Nadal
GCGuilherme dos Anjos Camargo
Guilherme dos Anjos Camargo
Andressa NovatskiAndressa Novatski
Andressa Novatski
WMWilliam Macenhan
William Macenhan
Daniele DiasDaniele Dias
Daniele Dias
PFPaulo Farago
Paulo Farago
Adapalene (ADAP) is an important drug widely used in the topical treatment of acne. It is a third-generation retinoid and provides keratolytic, anti-inflammatory, and antiseborrhoic action. However, some topical adverse effects such as erythema, dryness, and scaling have been reported with its commercial formula. In this sense, the microencapsulation of this drug using polyesters can circumvent its topical side effects and can lead to the enhancement of drug delivery into sebaceous glands. The goal of this work was to obtain ADAP-loaded poly(ε-caprolactone) (PCL) microparticles prepared by a simple emulsion/solvent evaporation method. Formulations containing 10 and 20% of ADAP were successfully obtained and characterized by morphological, spectroscopic, and thermal studies. Microparticles presented encapsulation efficiency of ADAP above 98% and showed a smooth surface and spherical shape. Fourier transform infrared spectroscopy (FTIR) results presented no drug-polymer chemical bond, and a differential scanning calorimetry (DSC) technique showed a partial amorphization of the drug. ADAP permeation in the Strat-M membrane for transdermal diffusion testing was evaluated by photoacoustic spectroscopy (PAS) in the spectral region between 225 and 400 nm after 15 min and 3 h from the application of ADAP-loaded PCL formulations. PAS was successfully used for investigating the penetration of polymeric microparticles. In addition, microencapsulation decreased the in vitro transmembrane diffusion of ADAP.